This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Levin, A. M. Articles by Douglas, J. A. Search for Related Content PubMed PubMed Citation Articles by Levin, A. M. Articles by Douglas, J. A.

Chromosome 17q12 Variants Contribute to Risk of Early-Onset Prostate Cancer

Departments of ¹ Human Genetics, ² Internal Medicine, and ³ Urology, University of Michigan Medical School, Ann Arbor, Michigan

Requests for reprints: Julie A. Douglas, Department of Human Genetics, University of Michigan Medical School, Room 5912, Buhl Building, 1241 East Catherine Street, Ann Arbor, MI 48109-5618. Phone: 734-615-2616; Fax: 734-763-2784; E-mail: jddoug{at}umich.edu.

Key Words: cancer • genetics • prostate • association • chromosome 17

In a recent genome-wide association study by Gudmundsson and colleagues, two prostate cancer susceptibility loci were identified on chromosome 17q. The first locus, at 17q12, was distinguished by two intronic single-nucleotide polymorphisms (SNPs) in the TCF2 gene (rs4430796 and rs7501939). The second locus was in a gene-poor region of 17q24, where the strongest evidence of association was for SNP rs1859962. To determine if these loci were also associated with hereditary prostate cancer, we genotyped them in a family-based association sample of 403 non-Hispanic white families, including 1,015 men with and without prostate cancer. SNPs rs4430796 and rs7501939, which were in strong linkage disequilibrium (r² = 0.68), showed the strongest evidence of prostate cancer association. Using a family-based association test, the A allele of SNP rs4430796 was overtransmitted to affected men (P = 0.006), with an odds ratio of 1.40 (95% confidence interval, 1.09–1.81) under an additive genetic model. Notably, rs4430796 was significantly associated with prostate cancer among men diagnosed at an early (<50 years) but not later age (P = 0.006 versus P = 0.118). Our results confirm the prostate cancer association with SNPs on chromosome 17q12 initially reported by Gudmundsson and colleagues. In addition, our results suggest that the increased risk associated with these SNPs is approximately doubled in individuals predisposed to develop early-onset disease. Importantly, these SNPs do not account for a significant portion of our prior prostate cancer linkage evidence on chromosome 17. Thus, there likely exist one or more additional independent prostate cancer susceptibility loci in this region. [Cancer Res 2008;68(16):6492–5]

This article has been cited by other articles:

				S.-P. Huang, L.-C. Huang, W.-C. Ting, L.-M. Chen, T.-Y. Chang, T.-L. Lu, Y.-H. Lan, C.-C. Liu, W.-H. Yang, H.-Z. Lee, et al. Prognostic Significance of Prostate Cancer Susceptibility Variants on Prostate-Specific Antigen Recurrence after Radical Prostatectomy Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 3068 - 3074. [Abstract] [Full Text] [PDF]

				J. L. Stanford, L. M. FitzGerald, S. K. McDonnell, E. E. Carlson, L. M. McIntosh, K. Deutsch, L. Hood, E. A. Ostrander, and D. J. Schaid Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage Hum. Mol. Genet., May 15, 2009; 18(10): 1839 - 1848. [Abstract] [Full Text] [PDF]

				K. L. Penney, C. A. Salinas, M. Pomerantz, F. R. Schumacher, C. A. Beckwith, G.-S. Lee, W. K. Oh, O. Sartor, E. A. Ostrander, T. Kurth, et al. Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer Mortality Clin. Cancer Res., May 1, 2009; 15(9): 3223 - 3230. [Abstract] [Full Text] [PDF]